Clinical trial
Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind…
NCT00009230 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00009230 |
|---|---|
| Title | Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled Trial |
| Lead sponsor | University of California, Los Angeles, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Memory Disorders |
| Intervention type | Drug |
| Interventions | Celecoxib |
| Start date | Jun 1, 2000 |
| Primary completion | Jun 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Jan 24, 2001 |
| Last update posted | Mar 2, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: